# Beijing Baiyinnuo Biotechnology

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/beijing-baiyinnuo-biotechnology

- Industry: Biotechnology
- Headquarters: Beijing, China
- Total disclosed funding: $31M
- Latest round: Series A (Dec 21, 2021)
- Investors on record: 8

## About

Established in 2019 and based in Beijing, China, Beijing Baiyinnuo Biotechnology is a technology company that provides biopharmaceutical CDMO and cell culture medium supply.

## Funding rounds

- Series A, Dec 21, 2021, $31M — Ciit Asset Management, Efung Capital, BridgeOne Capital, Hangzhou Aopeng Investment Management, Fuying Investment, Origins Capital, Taikun Fund
- Angel, Jul 1, 2020 — TigerYeah Capital

## Investors

- TigerYeah Capital (https://capitalatlas.ai/funds/tigeryeah-capital) — Angel
- Ciit Asset Management (https://capitalatlas.ai/funds/ciit-asset-management) — Series A
- Efung Capital (https://capitalatlas.ai/funds/efung-capital) — Series A
- BridgeOne Capital (https://capitalatlas.ai/funds/bridgeone-capital) — Series A
- Hangzhou Aopeng Investment Management (https://capitalatlas.ai/funds/hangzhou-aopeng-investment-management) — Series A
- Fuying Investment — Series A
- Origins Capital (https://capitalatlas.ai/funds/origins-capital) — Series A
- Taikun Fund — Series A